Glucose Health (OTCMKTS:GLUC – Get Free Report) is one of 51 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare Glucose Health to similar companies based on the strength of its risk, profitability, valuation, dividends, institutional ownership, earnings and analyst recommendations.
Profitability
This table compares Glucose Health and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Glucose Health | -75.00% | N/A | N/A |
Glucose Health Competitors | -42.21% | -22.72% | -7.72% |
Valuation and Earnings
This table compares Glucose Health and its competitors gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Glucose Health | $540,000.00 | -$420,000.00 | -5.71 |
Glucose Health Competitors | $309.39 million | -$49.38 million | -8.42 |
Institutional and Insider Ownership
15.6% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 20.9% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Glucose Health and its competitors, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Glucose Health | 0 | 0 | 0 | 0 | N/A |
Glucose Health Competitors | 272 | 537 | 980 | 74 | 2.46 |
As a group, “Medicinals & botanicals” companies have a potential upside of 41.95%. Given Glucose Health’s competitors higher possible upside, analysts clearly believe Glucose Health has less favorable growth aspects than its competitors.
Volatility and Risk
Glucose Health has a beta of 3.49, suggesting that its stock price is 249% more volatile than the S&P 500. Comparatively, Glucose Health’s competitors have a beta of 1.07, suggesting that their average stock price is 7% more volatile than the S&P 500.
About Glucose Health
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.